cautious

Novo Nordisk's stock price has fallen back to 2021 levels; analysts are cautiously optimistic about valuation recovery.

Danish pharmaceutical giant Novo Nordisk This year, the stock price plummeted, even regressing to levels seen in 2021 f...

Stock
2026-01-12